Michael A. Mont, MD, Kyle Low, MD, Dawn M. LaPorte, MD, Emmanuel Hostin, MD, Lynne C. Jones, PhD, David S. Hungerford, MD, Department of Orthopaedics, Johns Hopkins ...

A Medtronic (NYSE:MDT) official said today on LinkedIn that the company won CE mark for its Crescent RA jugular dual lumen ...

Shoreline's approach of developing off-the-shelf (allogeneic) cell therapies – which don't require the convoluted and time-consuming harvesting, modification and reinfusion of patient-derived ...

After hours: February 21 at 4:25:08 PM EST Loading Chart for ANGO ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Again, the researchers reinfused transduced cells 7 months later but were unable to detect evidence of FANCC-marked cells post this infusion. Post-transplant, the reinfusion was well tolerated, but in ...

A common aspect of all forms of ACT is in vitro culture, where mitogenic stimuli and cytokines are used to develop a high number of tumor-reactive T cells for reinfusion. In contrast to liquid ...

Multiple myeloma is part of the spectrum of diseases ranging from MGUS to plasma cell leukemia, and similar to MGUS, is characterized by proliferation of a plasma cell clone and subsequent ...